English
SpanishTrusted Resources: News & Meetings
Latest announcements and gatherings
SMA Screening Now Available to 87% of Newborns in US
Screening for spinal muscular atrophy (SMA), the leading genetic cause of infant death, is now available to 87% of all babies born in the United States, according to Cure SMA. The milestone was reached after Arizona and Louisiana began testing newborns for SMA this year, raising the number of states with the screening to 40.
Cure SMA conveyed the news in a Jan. 27 tweet: “Starting out 2022 strong! This month, Arizona and Louisiana officially begin screening newborns for spinal muscular atrophy. With these implementations, 87% of newborns in the U.S. are now being screened for SMA.” This comes four years after SMA was added to the federal Recommended Uniform Screening Panel (RUSP).
Source: https://smanewstoday.com/news-posts/2022/01/31/sma-screening-now-available-87-percent-us-newborns/
BookmarkRelated Content
-
Integrating Newborn Screening for Spinal Muscular Atrophy Into Health Care Systems: An Australian Pilot ProgrammeAim: This study dynamically designed, ev...
-
SMA: Considerations for Newborn Screening and Managementhttps://www.youtube.com/watch?v=FkshzHlc...
-
Baby First at UNC to Receive Gene Therapy for SMA, Thanks to Early Check Newborn ScreeningIt was a pregnancy that went relatively ...
-
Newborn Screening, Treatment Make Big Difference With Rare Muscle DisorderMateo Medina has never walked or talked....
-
Parent Perceptions in Choosing Treatment for Infants With Spinal Muscular Atrophy Diagnosed Through Newborn Screenin...Objective: To identify factors parents c...
-
Screening of Neonatal UK Dried Blood Spots Using a Duplex SMN1 Screening AssaySpinal muscular atrophy (SMA) is an auto...
-
Why Texas Added Spinal Muscular Atrophy to Required Screenings for NewbornsKERA’s Sam Baker talks with Dr. Angela...
Powered by
In partnership with
